*New* Slator Pro Guide: Scaling an LSP Key Account — Growing Small Clients into Key Accounts
UCLA researchers examined consent document translation data, concluding that high translation costs hinder participation in clinical studies by underrepresented groups.
Clinical research organization, Clario, invests in proprietary translation technology in hopes of reducing translation turnaround times by up to 30%. LSPs should take note.
US-based clinical research provider WCG acquires VeraSci, a provider of e-clinical software and translation, for USD 330m; plans Nasdaq IPO.
Where is demand for language services and technology heading in 2016, and what should providers know about the trends affecting buyers? Download Slator's 2015/16 Demand Driver report.
CROs have become some of the language industry’s most coveted and profitable clients with accounts potentially exceeding 5mn USD or more in annual billings.
As CROs are increasingly relying on ePRO in clinical trials, the demand for translation and localization of ePRO systems may likewise increase.
Slator Weekly: Join over 15,800 subscribers and get the latest language industry intelligence every Friday
Tool Box: Join 10,000 subscribers for your monthly linguist technology update.
Your information will not be shared with third parties. No Spam.
This will close in 0 seconds